Myriad Therapeutics

Myriad Genetics is a leading precision medicine and molecular diagnostics company that develops and commercializes genetic tests to assess disease risk, guide treatment decisions, and monitor disease progression. The company is best known for its pioneering work in hereditary cancer testing, particularly the discovery of the BRCA1 and BRCA2 genes and the development of the BRACAnalysis test. Myriad's current product portfolio includes tests for oncology (MyRisk, Prolaris, Precise MRD), mental health (GeneSight), and women's health (Prequel, Foresight). Headquartered in Salt Lake City, Utah, the company operates high-complexity clinical laboratories and serves patients and healthcare providers globally.